Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RARG | P13631 | 1/20 | 0.31 |
| ▸ | CYP26A1 | O43174 | 1/20 | 0.31 |
| ▸ | CYP26B1 | Q9NR63 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4874704 | 0.86 | CYP26B1 (0.36) | RARGCYP26A1CYP26B1 | |
| SCHEMBL4874210 | 0.86 | CYP26B1 (0.43) | RARGCYP26A1CYP26B1 | |
| SCHEMBL4873614 | 0.85 | RARG (0.31) | RARGCYP26A1CYP26B1 | |
| SCHEMBL4873599 | 0.73 | FOLH1 (0.34) | — | |
| SCHEMBL4871616 | 0.73 | SLC1A3 (0.39) | — | |
| SCHEMBL4868661 | 0.72 | KIF11 (0.35) | — | |
| SCHEMBL4874211 | 0.71 | CYP26B1 (0.43) | RARGCYP26A1CYP26B1 | |
| SCHEMBL4874711 | 0.71 | CYP26B1 (0.36) | RARGCYP26A1CYP26B1 | |
| SCHEMBL6682067 | 0.71 | GGPS1 (0.45) | — | |
| SCHEMBL4873572 | 0.70 | FFAR1 (0.36) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7402576-B2 | Phosphinic acid analogs of glutamate | GIVAUDAN SA (CH) | 2008-07-22 | — | — | US | disclosed |
| EP-1599487-B1 | PHOSPHINIC ACID ANALOGS OF GLUTAMATE | GIVAUDAN SA (CH) | 2007-07-11 | — | — | EP | disclosed |
| US-20060052616-A1 | Phosphinic acid analogs of glutamate | GIVAUDAN SA (CH) | 2006-03-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060052616-A1 | Phosphinic acid analogs of glutamate | GLUL, GRIA1, GRM1 | RARG 1024/4885CYP26A1 3974/4885CYP26B1 3918/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.